|1.||Moretto, A: 2 articles (03/2007 - 02/2000)|
|2.||Lotti, M: 2 articles (03/2007 - 02/2000)|
|3.||Pasqualato, Fabiola: 1 article (09/2010)|
|4.||Lotti, Marcello: 1 article (09/2010)|
|5.||Gambalunga, Alberto: 1 article (09/2010)|
|6.||Nicolli, A: 1 article (03/2007)|
|7.||Carrera, V: 1 article (06/2004)|
|8.||Sogorb, M A: 1 article (06/2004)|
|9.||Vilanova, E: 1 article (06/2004)|
|10.||Quesada, E: 1 article (06/2004)|
09/06/2010 - "Soluble phenyl valerate esterases of hen sciatic nerve and the potentiation of organophosphate induced delayed polyneuropathy."
03/01/2007 - "Given the biochemical and toxicological characteristics of these compounds, the hypothesis was made that the target of promotion is a phenyl valerate (PV) esterase similar to neuropathy target esterase (NTE), the target of organophosphate induced delayed polyneuropathy. "
09/01/1997 - "Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy."
02/01/2000 - "Neuropathy target esterase (NTE), thought to be the target for organophosphate polyneuropathy, is operationally defined as that neural phenyl valerate esterase resistant to paraoxon (40 microM) and sensitive to mipafox (50 microM; 20 min, pH 8.0, 37 degrees C). "
06/15/2004 - "Organophosphorus-induced polyneuropathy is a syndrome related to the inhibition and further modification by organophosphorus compounds of NTE (a protein that displays phenyl valerate esterase activity resistant to mipafox and sensitive to paraoxon). "
|4.||Staphylococcal Protein A (A, Protein)